Renaissance Technologies LLC Has $989,000 Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Renaissance Technologies LLC reduced its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 44.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 7,500 shares of the medical instruments supplier’s stock after selling 5,900 shares during the period. Renaissance Technologies LLC’s holdings in Mesa Laboratories were worth $989,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of MLAB. Resona Asset Management Co. Ltd. acquired a new position in Mesa Laboratories during the fourth quarter valued at $92,000. ExodusPoint Capital Management LP grew its stake in Mesa Laboratories by 283.8% during the 4th quarter. ExodusPoint Capital Management LP now owns 9,692 shares of the medical instruments supplier’s stock valued at $1,278,000 after acquiring an additional 7,167 shares in the last quarter. Alliancebernstein L.P. increased its holdings in shares of Mesa Laboratories by 2.6% in the 4th quarter. Alliancebernstein L.P. now owns 5,584 shares of the medical instruments supplier’s stock valued at $736,000 after purchasing an additional 141 shares during the period. Wellington Management Group LLP purchased a new stake in shares of Mesa Laboratories in the fourth quarter worth approximately $1,888,000. Finally, Vanguard Group Inc. boosted its holdings in shares of Mesa Laboratories by 1.4% during the fourth quarter. Vanguard Group Inc. now owns 382,856 shares of the medical instruments supplier’s stock worth $50,487,000 after purchasing an additional 5,274 shares during the period. Hedge funds and other institutional investors own 90.60% of the company’s stock.

Insider Activity

In related news, CEO Gary M. Owens sold 21,000 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $123.91, for a total value of $2,602,110.00. Following the transaction, the chief executive officer now owns 43,337 shares in the company, valued at approximately $5,369,887.67. This represents a 32.64 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 4.40% of the stock is owned by corporate insiders.

Mesa Laboratories Stock Down 1.8 %

Mesa Laboratories stock opened at $115.25 on Thursday. Mesa Laboratories, Inc. has a twelve month low of $83.68 and a twelve month high of $155.12. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.53 and a current ratio of 0.71. The firm has a market cap of $626.27 million, a PE ratio of -2.49 and a beta of 0.92. The firm’s 50 day moving average price is $122.02 and its two-hundred day moving average price is $126.96.

Mesa Laboratories (NASDAQ:MLAB) last posted its quarterly earnings results on Tuesday, February 4th. The medical instruments supplier reported $2.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.66. Mesa Laboratories had a negative net margin of 104.92% and a positive return on equity of 30.23%. On average, research analysts predict that Mesa Laboratories, Inc. will post 8 EPS for the current fiscal year.

Mesa Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Friday, May 30th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date of this dividend is Friday, May 30th. Mesa Laboratories’s dividend payout ratio (DPR) is presently -1.38%.

About Mesa Laboratories

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.